<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04069806</url>
  </required_header>
  <id_info>
    <org_study_id>PUM_08.08.2019</org_study_id>
    <nct_id>NCT04069806</nct_id>
  </id_info>
  <brief_title>Preoperative Oral Carbohydrate for Nausea and Vomiting Prevention During Cesarian Section</brief_title>
  <acronym>POC-NaVoP</acronym>
  <official_title>An Analysis of Risk Factors and Implementation of Strategies to Prevent Nausea and Vomiting in Patients Undergoing Regional Anesthesia for Caesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pomeranian Medical University Szczecin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pomeranian Medical University Szczecin</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Post-operative nausea and vomiting (PONV) in women undergoing subarachnoid anesthesia for
      Caesarean section is an important clinical problem. The aim of this study is to compare the
      effectiveness of oral carbohydrate loading to standard pre-operative fasting in patients
      undergoing elective cesarean section on the incidence and severity of PONV and biochemical
      parameters indicating ketosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Post-operative nausea and vomiting (PONV) in women undergoing subarachnoid anesthesia for
      Caesarean section is an important clinical problem. Known mechanisms underlying PONV are
      based on prolonged fasting, hypotension due to concomitant sympatholysis during anesthesia,
      bradycardia due to increased vagal tone, visceral stimulation during surgery and intrathecal
      administered opioids. However, the identification of patients exposed to this problem and
      appropriate perioperative preparation is of key importance. An analysis of risk factors for
      postoperative nausea and vomiting in patients undergoing elective cesarean section under
      spinal anesthesia is of major clinical importance. The aim of this study is a comparison of
      the effectiveness of oral carbohydrate loading strategy as compared with standard
      pre-operative fasting in patients undergoing elective cesarean section under spinal
      anesthesia on the incidence and severity of PONV and biochemical parameters indicating
      ketosis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 3, 2019</start_date>
  <completion_date type="Anticipated">August 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative nausea and vomiting 6 hours after caesarian section.</measure>
    <time_frame>6 hours</time_frame>
    <description>The Postoperative Nausea and Vomiting (PONV) Intensity Scale 6 hours after caesarian section. Scale range: 0-50. The scale measures PONV intensity, where a score ≥50 defined clinically important PONV: PONV Intensity Scale=severity of nausea (1=mild, 2=moderate, 3=severe)×pattern of nausea (1=varying, 2=constant)×duration of nausea (in hours).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative nausea and vomiting 24 hours after caesarian section.</measure>
    <time_frame>24 hours</time_frame>
    <description>The Postoperative Nausea and Vomiting (PONV) Intensity Scale 24 hours after caesarian section. Scale range: 0-50. The scale measures PONV intensity, where a score ≥50 defined clinically important PONV: PONV Intensity Scale=severity of nausea (1=mild, 2=moderate, 3=severe)×pattern of nausea (1=varying, 2=constant)×duration of nausea (in hours).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to first peristalsis.</measure>
    <time_frame>24 hours</time_frame>
    <description>Moment of first peristalsis after operation (in hours).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first bowel movement.</measure>
    <time_frame>24 hours</time_frame>
    <description>Moment of first bowel movement after operation (in hours).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concentration of serum lactate in serum.</measure>
    <time_frame>0 hours</time_frame>
    <description>Lactate level measured in maternal serum.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concentration of beta-hydroxy-butiric acid in serum.</measure>
    <time_frame>0 hours</time_frame>
    <description>Beta-hydroxy-butiric acid level measured in maternal serum.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin resistance factor (HOMA-IR).</measure>
    <time_frame>0 hours</time_frame>
    <description>Insulin resistance measured in maternal serum.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concentration of isoprostane in urine.</measure>
    <time_frame>0 hours</time_frame>
    <description>Isoprostane level measured in maternal urine.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Postoperative Nausea and Vomiting</condition>
  <arm_group>
    <arm_group_label>Preoperative oral carbohydrate load</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>6 hours for solid food and 2 hours for liquids + oral carbohydrate preparation 2 hours prior to surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard preoperative fasting</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>6 hours for solid food and 2 hours for liquids.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>preoperative oral carbohydrate, preOp</intervention_name>
    <description>Patients in the experimental arm will receive oral carbohydrate preparation at 2 hours prior to planned caesarian section.</description>
    <arm_group_label>Preoperative oral carbohydrate load</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age &gt;=18 years.

          2. Scheduled for an elective cesarean section.

          3. Uncomplicated pregnancy.

          4. Planned for spinal anesthesia.

          5. ASA I or ASA II.

        Exclusion Criteria:

          1. History of diabetes.

          2. History of gastro-intestinal reflux (GERD).

          3. Unable or unwilling to sign an informed consent.

          4. Contraindications to spinal anesthesia.

          5. Contraindication to Oral carbohydrate formula.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Pregnant patients scheduled for planned cesarian section.</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katarzyna L Kotfis, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pomeranian Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sebastian Kwiatkowski, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Pomeranian Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Katarzyna L Kotfis, MD, PhD</last_name>
    <phone>0048914661144</phone>
    <email>katarzyna.kotfis@pum.edu.pl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Arleta Wojciechowska, RN</last_name>
    <email>arletawoj@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Pomeranian Medical University</name>
      <address>
        <city>Szczecin</city>
        <zip>70-111</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katarzyna L Kotfis, MD</last_name>
      <phone>0048914661144</phone>
      <email>katarzyna.kotfis@pum.edu.pl</email>
    </contact>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>August 23, 2019</study_first_submitted>
  <study_first_submitted_qc>August 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2019</study_first_posted>
  <last_update_submitted>September 3, 2019</last_update_submitted>
  <last_update_submitted_qc>September 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pomeranian Medical University Szczecin</investigator_affiliation>
    <investigator_full_name>Katarzyna Kotfis</investigator_full_name>
    <investigator_title>Primary Investigator</investigator_title>
  </responsible_party>
  <keyword>Nausea</keyword>
  <keyword>Vomiting</keyword>
  <keyword>Oral carbohydrate</keyword>
  <keyword>Fasting</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

